期刊文献+

高密度脂蛋白3介导大鼠腹腔巨噬细胞内胆固醇流出 被引量:3

Cholesterol Efflux from Macrophages Mediated by High Density Lipoprotein-3
在线阅读 下载PDF
导出
摘要 为了研究高密度脂蛋白 3介导大鼠腹腔巨噬细胞内胆固醇流出的机理 ,用N -乙酰咪唑修饰高密度脂蛋白 3,阻断其与细胞表面受体的结合 ,观察细胞内胆固醇流出。用异硫氰酸荧光素酯标记高密度脂蛋白 3,示踪其在细胞内的代谢。结果发现牛血清白蛋白 (对照组 )介导 2 .87%细胞内胆固醇流出 ,高密度脂蛋白 3组和N -乙酰咪唑 -高密度脂蛋白 3组分别为 40 .6 8%和 8.6 9%。异硫氰酸荧光素酯 -高密度脂蛋白 3与细胞在 37℃共育 3h后 ,细胞内吞荧光强度占结合的 6 5 .0 % ,细胞在 37℃继续培养 2h后 ,细胞释放的荧光强度占内吞的 78.4% ,并且内吞和释放的荧光强度均主要存在于三氯醋酸沉淀部分。结果提示高密度脂蛋白 3通过与细胞表面受体作用进入细胞 ,在细胞内不经过溶酶体途径降解 。 Aim To study the mechanism of cholesterol efflux from rat peritoneal macrophages mediated by high density lipoprotein-3(HDL 3). Methods Modification of HDL 3 by N-acetylimidazole blocked interaction between HDL and its cellular receptor. FITC labeled HDL 3 were used to observed the cellular metabolic process of HDL 3. Results BSA (control group) mediated 2.9% cellular cholesterol efflux from the cells. In HDL 3 group and N-acetylimidazole-HDL 3 group,they were 40.7% and 8.7% respectively. After incubation of macrophages with FITC-HDL 3 at 37℃for 3 h, the cell-endocytic fluorescence strength (FS) was 65.0% of the cell-associated FS. When the cells were further incubated with blank media at 37℃for 2 h, 78.4% of the cell-endocytic FS was released into the media. Both the cell-endocytic FS and the cell-released FS were mainly in trichloroacetic acid precepitable form. Conclusions The cellular cholesterol efflux from macrophages mediated by HDL 3 was HDL receptor-dependent. The possible mechanism could be that macrophages internalized HDL 3 by HDL receptor. HDL 3 picked up cellular cholesterol and was resecreted out of cells by a retroendocytic pathway without taking a celluar lysosomal phathway.
出处 《中国动脉硬化杂志》 CAS CSCD 2000年第2期111-114,共4页 Chinese Journal of Arteriosclerosis
基金 国家自然科学基金资助课题!(项目编号39570158)
  • 相关文献

参考文献1

二级参考文献2

共引文献3

同被引文献51

  • 1刘本君,郭宏军,葛佳瑞,康波.多不饱和脂肪酸与肿瘤关系的研究进展[J].畜牧兽医科技信息,2007,23(5):7-8. 被引量:3
  • 2亢爱春,霍勇,齐丽彤.溶血磷脂酰胆碱在动脉粥样硬化中的作用[J].中国动脉硬化杂志,2006,14(12):1083-1086. 被引量:27
  • 3[1]Sensel MG, Legrand-Lorans A, Wang ME, Bensadoun A. Isolation and characterization of clones for the rat hepatic lipase gene upstream regulatory region. Biochim Biophys Acta, 1990, 6 (2-3): 297-302
  • 4[2]DM Cai SJ, Wong DM, Chen SH. Structure of the human hepatic triglyceride lipase gene. Bioemistry, 1989, 28 (23): 8 966-971
  • 5[3]Philip W, Connelly. The role of hepatic lipase in lipoprotein metabolism. Clinica Chimica Acta, 1999, 286: 243-255
  • 6[4]Cisar LA, Melford KH, Sensel M, Bensadoun A. Heparin decreases the degradation rate of hepatic lipase in Fu5AH rat hepatoma cells. A model for hepatic lipase efflux from hepatocytes. Biochim Biophys Acta, 1989, 1 004 (2): 196-204
  • 7[5]Cheung AK, Parker CJ, Ren K, Iverius PH. Increased lipase inhibition in uremia: identification of pre-beta-HDL as a major inhibitor in normal and uremic plasma. Kidney Int, 1996, 49: 1 360-371
  • 8[7]Zambon A, Deeb SS, Bensadoun A. In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activity. J Lipid Res, 2000, 41 (12): 2 094-099
  • 9[8]Lambert G, Chase MB, Santamarina FS. Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptor B1. J Lipid Res, 1999, 40 (7): 1 294-303
  • 10[9]De Faria E, Fong LG, Komaromy M, Cooper AD. Relative roles of the LDL receptor, the LDL receptor-like protein, and hepatic lipase in chylomicron remnant removal by the liver. J Lipid Res, 1996, 37 (1): 197-209

引证文献3

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部